Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130) on September 21, 2023. The Pharmaceutical business generated annual sales of KRW 313.9 billion in 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54,000 KRW | +0.56% | -6.25% | -19.76% |
May. 28 | SK Chemicals Introduces Sustainable Packaging Solutions | MT |
May. 21 | SK Chemicals Implements Safety Evaluation System at Ulsan Plant | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.76% | 718M | |
+5.84% | 40.62B | |
-21.64% | 22.05B | |
-15.28% | 13.15B | |
-6.04% | 10.19B | |
-11.72% | 9.79B | |
+24.18% | 8.57B | |
+4.78% | 6.56B | |
-31.26% | 5.29B | |
-24.67% | 3.65B |
- Stock Market
- Equities
- A285130 Stock
- News SK Chemicals Co.,Ltd
- Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd.